Skip to main content
Advanced Search
Search Terms
Content Type

Exact Matches
Tag Searches
Date Options
Updated after
Updated before
Created after
Created before

Search Results

7273 total results found

65 - Menopause

Maudsley's guidelines 15 - Chapter 10 Drug treatment of psych...

Menopause

66 - Diagnosis

Maudsley's guidelines 15 - Chapter 10 Drug treatment of psych...

Diagnosis Drug treatment of psychiatric symptoms in the context of other conditions CHAPTER 10 Menopause The menopause transition is a phase in a woman’s reproductive life where ovarian function declines, menstruation stops and production of the female reprodu...

67 - Psychological symptoms of the menopause

Maudsley's guidelines 15 - Chapter 10 Drug treatment of psych...

Psychological symptoms of the menopause 858 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 10 Psychological symptoms of the menopause Depression and anxiety The impact of the menopause on mental well-­being is significant. Suicidal ideation is pres...

68 - Elderly care

Maudsley's guidelines 15 - Chapter 10 Drug treatment of psych...

Elderly care

69 - Use of HRT

Maudsley's guidelines 15 - Chapter 10 Drug treatment of psych...

Use of HRT Drug treatment of psychiatric symptoms in the context of other conditions CHAPTER 10 Elderly care Genitourinary symptoms of menopause (GSM) may be a factor in agitation and aggression in elderly care. Consider vaginal atrophy and localised vaginal o...

70 - References

Maudsley's guidelines 15 - Chapter 10 Drug treatment of psych...

References Drug treatment of psychiatric symptoms in the context of other conditions CHAPTER 10 Starting treatment Start HRT at 25–50mcg estradiol patch dose equivalents (1mg estradiol tablet/1–2 pumps estradiol 0.6mg/g gel). Increase after 6–8 weeks if sympto...

01 - Plasma level monitoring of psychotropic drugs

Maudsley's guidelines 16 - Chapter 11 Pharmacokinetics

Plasma level monitoring of psychotropic drugs

02 - First order pharmacokinetics

Maudsley's guidelines 16 - Chapter 11 Pharmacokinetics

First-order pharmacokinetics

03 - Steady state

Maudsley's guidelines 16 - Chapter 11 Pharmacokinetics

Steady state The Maudsley® Prescribing Guidelines in Psychiatry, Fifteenth Edition. David M. Taylor, Thomas R. E. Barnes and Allan H. Young. © 2025 David M. Taylor. Published 2025 by John Wiley & Sons Ltd. Chapter 11 Plasma level monitoring of psychotropic dru...

04 - Timing of sampling

Maudsley's guidelines 16 - Chapter 11 Pharmacokinetics

Timing of sampling 866 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 11 to know when a drug is or is not at steady state but there are two concepts connected to steady state that are often misunderstood. ■ ■Time to reach steady state follows a log...

05 - Interpretation of results

Maudsley's guidelines 16 - Chapter 11 Pharmacokinetics

Interpretation of results

06 - Target ranges

Maudsley's guidelines 16 - Chapter 11 Pharmacokinetics

Target ranges Pharmacokinetics CHAPTER 11 Interpretation of results Is there a target range of plasma levels? If so, then plasma levels (from samples taken at the right time) will usefully guide dosing. If there is not an accepted target range, plasma levels c...

07 - Amisulpride

Maudsley's guidelines 16 - Chapter 11 Pharmacokinetics

Amisulpride Pharmacokinetics CHAPTER 11 Amisulpride Amisulpride plasma levels are closely related to dose with insufficient variation to make routine plasma level monitoring prudent. Higher levels observed in women27–29 seem to have little significant clinical...

08 - Aripiprazole

Maudsley's guidelines 16 - Chapter 11 Pharmacokinetics

Aripiprazole

09 - Clozapine

Maudsley's guidelines 16 - Chapter 11 Pharmacokinetics

Clozapine 870 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 11 psychosis, studies suggest plasma concentrations of 20–60mcg/L may give optimal D2 occupancy and clinical response.34,35 In practice, only a minority of treated patients have ‘therapeu...

10 - Olanzapine

Maudsley's guidelines 16 - Chapter 11 Pharmacokinetics

Olanzapine Pharmacokinetics CHAPTER 11 an individual’s clozapine plasma levels are common with a tendency for concentrations to slightly decrease over time,72 although one study suggests a decrease only in norclozapine concentrations.73 Despite these somewhat ...

11 - Quetiapine

Maudsley's guidelines 16 - Chapter 11 Pharmacokinetics

Quetiapine 872 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 11 further therapeutic benefit than lower levels.94 Severe toxicity is uncommon but may be associated with levels above 100mcg/L, and death is occasionally seen at levels above 160mcg/L9...

12 - Risperidone

Maudsley's guidelines 16 - Chapter 11 Pharmacokinetics

Risperidone